Quest Diagnostics, Inc. (DGX)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
SERVICES-MEDICAL LABORATORIES
CEO:
Stephen H. Rusckowski
Employees:
46,000
500 PLAZA DRIVE, SECAUCUS, NJ 07094
9735202700

Quest Diagnostics, Inc. is engaged in providing diagnostic testing, information and services that help patients, physicians and others to make better healthcare decisions. The company operates through two segments: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services segment comprised of two parts develops and delivers diagnostic testing, information and services to patients, physicians, health plans, hospitals, ACOs, IDNs, employers and others. It provides diagnostic information services, which includes clinical testing services such as routine testing, gene-based and esoteric testing, anatomic pathology services, as well as related services and insights. The Diagnostic Solutions includes other businesses such as risk assessment services, clinical trials testing, diagnostic products and healthcare information technology. Quest Diagnostics was founded on December 31, 1996 and is headquartered in Madison, NJ.

Data derived from most recent annual or quarterly report
Market Cap 19.19 Billion Shares Outstanding122.181 Million Avg 30-day Volume 1.302 Million
P/E Ratio9.5739 Dividend Yield1.7538 EPS4.11
Price to Revenue1.6684 Debt to Equity0.5841 EBITDA2.929 Billion
Price to Book Value2.5564 Operating Margin23.7639 Enterprise Value19.622 Billion
Current Ratio1.757 EPS Growth1.272 Quick Ratio1.53
1 Yr BETA 0.1574 52-week High/Low 159.87 / 111.81 Profit Margin18.2196
Operating Cash Flow Growth104.856 Altman Z-Score3.8964 Free Cash Flow to Firm 1.706 Billion
View SEC Filings from DGX instead.

View recent insider trading info

Funds Holding DGX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DGX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

37.6 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

37.6 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DOHERTY CATHERINE T. SVP, GROUP EXEC. CLIN. FRAN.

  • Officer
72,865 2021-11-29 5

RING TIMOTHY M

  • Director
11,337 2021-10-01 5

DOI TRACEY

  • Director
0 2021-08-16 2

RUSCKOWSKI STEPHEN H CHAIRMAN, CEO AND PRESIDENT

  • Officer
  • Director
578,347 2021-07-28 5

WILENSKY GAIL R

  • Director
31,220 2021-07-27 2

PFEIFFER GARY M

  • Director
23,265 2021-05-25 1

MAIN TIMOTHY L

  • Director
20,951 2021-05-25 1

MORRISON DENISE M

  • Director
5,206 2021-05-25 1

TORLEY HELEN

  • Director
6,260 2021-05-25 1

LASSITER WRIGHT III

  • Director
3,281 2021-05-25 1

GREGG VICKY B

  • Director
15,400 2021-05-21 1

DEPPE MICHAEL J VP, CORP. CONTROLLER & CAO

  • Officer
27,503 2021-05-18 4

PREVOZNIK MICHAEL E SVP & GENERAL COUNSEL

  • Officer
45,385 2021-05-05 5

GUINAN MARK EXECUTIVE VICE PRESIDENT & CFO

  • Officer
88,792 2021-03-09 4

DAVIS J. E. EVP, GENERAL DIAGNOSTICS

  • Officer
49,931 2021-03-09 3

EGLINTON MANNER CARRIE SVP, ADVANCED DIAGNOSTICS

  • Officer
66,644 2021-03-09 4

MENDEZ MANUEL O. SVP & CHIEF COMMERCIAL OFFICER

  • Officer
56,678 2021-02-17 1

STANZIONE DANIEL

  • Director
28,349 2020-11-23 0

KLUG ROBERT A VP, CORPORATE CONTROLLER

  • Officer
6,261 2019-03-01 0

CUNNINGHAM EVERETT SVP, COMMERCIAL

  • Officer
39,032 2019-03-01 0

BRITELL JENNE K

  • Director
14,479 2018-06-04 0

LEIDEN JEFFREY M

  • Director
6,000 2018-05-29 0

COHEN JON R SVP & GROUP EXEC. DIAG. SOL.

  • Officer
31,757 2018-03-08 0

ZIEGLER JOHN B

  • Director
16,557 2017-02-22 0

BALDWIN JOHN C MD

  • Director
12,949 2015-08-12 0

BONGIORNO THOMAS F VP AND CORPORATE CONTROLLER

  • Officer
15,002 2015-02-27 0

HAYDON JOHN B. SVP, OPERATIONS

  • Officer
19,890 2014-02-13 0

BUEHLER WILLIAM F

  • Director
26,225 2014-02-12 0

ORDONEZ KATHY SVP, DIAGNOSTIC SOLUTIONS

  • Officer
9,569 2013-03-31 0

HAGEMANN ROBERT SVP & CHIEF FINANCIAL OFFICER

  • Officer
162,520 2013-03-05 0

MOHAPATRA SURYA N CHAIRMAN, PRESIDENT & CEO

  • Officer
  • Director
No longer subject to file 2012-04-30 0

MILLER JOAN ELIZABETH SVP-ONCOLOGY & NEUROLOGY SRVCS

  • Officer
90,279 2012-02-29 0

SIMMONS WAYNE R. VICE PRESIDENT, OPERATIONS

  • Officer
47,752 2011-06-16 0

GLAXOSMITHKLINE PLC

  • Director
  • 10% Owner
No longer subject to file 2011-01-31 0

HAGGERTY ROSANNE

  • Director
9,334 2010-05-06 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DOHERTY CATHERINE T. - Officer SVP, GROUP EXEC. CLIN. FRAN.

2021-12-01 16:34:23 -0500 2021-11-29 M 37,565 $95.80 a 106,294 direct yes 1.7755 1.7755 2 0.0 1

DOHERTY CATHERINE T. - Officer SVP, GROUP EXEC. CLIN. FRAN.

2021-12-01 16:34:23 -0500 2021-11-29 S 14,575 $157.53 d 68,729 direct yes 1.7755 1.7755 2 0.0 1

DOHERTY CATHERINE T. - Officer SVP, GROUP EXEC. CLIN. FRAN.

2021-12-01 16:34:23 -0500 2021-11-29 S 3,250 $154.79 d 102,744 direct yes 1.7755 1.7755 2 0.0 1

DOHERTY CATHERINE T. - Officer SVP, GROUP EXEC. CLIN. FRAN.

2021-12-01 16:34:23 -0500 2021-11-29 S 15,908 $156.86 d 83,304 direct yes 1.7755 1.7755 2 0.0 1

DOHERTY CATHERINE T. - Officer SVP, GROUP EXEC. CLIN. FRAN.

2021-12-01 16:34:23 -0500 2021-11-29 S 300 $153.38 d 105,994 direct yes 1.7755 1.7755 2 0.0 1

DOHERTY CATHERINE T. - Officer SVP, GROUP EXEC. CLIN. FRAN.

2021-12-01 16:34:23 -0500 2021-11-29 M 37,565 $95.80 d 0 direct yes

DOHERTY CATHERINE T. - Officer SVP, GROUP EXEC. CLIN. FRAN.

2021-12-01 16:34:23 -0500 2021-11-29 S 3,532 $155.77 d 99,212 direct yes 1.7755 1.7755 2 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
QUEST DIAGNOSTICS INC DGX 2021-12-03 22:15:03 UTC -0.23 0.3 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 21:45:03 UTC -0.23 0.3 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 21:15:04 UTC -0.23 0.3 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 20:45:03 UTC -0.2241 0.2941 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 20:15:03 UTC -0.2241 0.2941 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 19:45:03 UTC -0.2241 0.2941 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 19:15:04 UTC -0.2241 0.2941 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 18:45:04 UTC -0.2486 0.3186 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 18:15:03 UTC -0.2486 0.3186 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 17:45:03 UTC -0.2486 0.3186 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 17:15:03 UTC -0.2486 0.3186 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 16:45:03 UTC -0.2678 0.3378 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 16:15:04 UTC -0.2678 0.3378 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 15:45:03 UTC -0.2678 0.3378 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 15:15:03 UTC -0.2678 0.3378 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 14:45:03 UTC -0.1975 0.2675 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 14:15:05 UTC -0.1975 0.2675 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 13:45:03 UTC -0.1975 0.2675 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 13:15:03 UTC -0.1975 0.2675 4100000
QUEST DIAGNOSTICS INC DGX 2021-12-03 12:45:03 UTC -0.1975 0.2675 4100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund DGX -384.0 shares, $-54451.2 2021-07-31 N-PORT
Weiss Strategic Interval Fund- Weiss Strategic Interval Fund DGX -6885.0 shares, $-1000459.35 2021-09-30 N-PORT

Elevate your investments